Clinical Trial Update: Study to Evaluate Safety and Efficacy of Mirivadelgat in PH-ILD [Phase 2]

View source ↗

Summary

Phase 2 study to evaluate the safety and efficacy of Mirivadelgat in pulmonary hypertension due to interstitial lung disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension Due to Interstitial Lung Disease

Drugs mentioned

• Mirivadelgat

Snippet

Sponsor: Foresee Pharmaceuticals Co., Ltd. | Conditions: Group 3 Pulmonary Hypertension | Phase 2 | Status: RECRUITING